http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0498899-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b151fc61aa26849d7d1df7a9d66cfe2 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-425 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 |
filingDate | 1990-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2cd8543149a3397beb8a376796b1a2a |
publicationDate | 1992-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-0498899-A1 |
titleOfInvention | Use of N-(mercaptoacyl)-amino acids as dopaminergic und gonadoptropic medicaments |
abstract | N- (Mercaptoacyl) amino acids and their salts are used for the production of dopaminergic, gonadotropic and prolactin-lowering pharmaceutical preparations and pharmaceuticals. The compounds, in particular (2R, 4R) -2- (2-hydroxyphenyl) -3- (3-mercaptopropionyl) -4-thiazolidinecarboxylic acid and 1 - [(2S) -3-mercapto-2-methylpropionyl] -2-proline, cause both peripheral and cerebral blood flow to increase. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5589499-A |
priorityDate | 1989-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 102.